The tumor growth inhibition in mice from Group C and D that received 2 × 3 MBq 149Tb-PSMA-617 at Day 0 and Day 1 or at Day 0 and Day 3, respectively, was comparable between the two groups. The gene discussed is FOLH1; the disease is neoplasm.